The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers
Open accessAbstract
Chemical and enzymatic barriers in the gastrointestinal (GI) tract hamper the oral delivery of many labile drugs. The GI epithelium also contributes to poor permeability for numerous drugs. Drugs with poor aqueous solubility have difficulty dissolving in the GI tract, resulting in low bioavailability. Nanomedicine provides an opportunity to improve the delivery efficiency of orally administered drugs. Solid lipid nanoparticles (SLNs) are categorized as a new generation of lipid nanoparticles consisting of a complete solid lipid matrix. SLNs used for oral administration offer several benefits over conventional formulations, including increased solubility, enhanced stability, improved epithelium permeability and bioavailability, prolonged half-life, tissue targeting, and minimal side effects. The nontoxic excipients and sophisticated material engineering of SLNs tailor the controllable physicochemical properties of the nanoparticles for GI penetration via mucosal or lymphatic transport. In this review, we highlight the recent progress in the development of SLNs for disease treatment. Recent application of oral SLNs includes therapies for cancers, central nervous system-related disorders, cardiovascular-related diseases, infection, diabetes, and osteoporosis. In addition to drugs that may be active cargos in SLNs, some natural compounds with pharmacological activity are also suitable for SLN encapsulation to enhance oral bioavailability. In this article, we systematically introduce the concepts and amelioration mechanisms of the nanomedical techniques for drug- and natural compound-loaded SLNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S.-D., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,568
Mechanisms of nanotoxicity: Generation of reactive oxygen species
Fu, P. P., Xia, Q., Hwang, H.-M., Ray, P. C., & Yu, H. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.005 · Cited by 1,398
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.1.2 · Cited by 1,057
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles
Li, H., Zhao, X., Ma, Y., Zhai, G., Li, L., & Lou, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.002 · Cited by 666
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
Pharmacological Effects of Formulation Vehicles: Implications for Cancer Chemotherapy
ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342070-00005 · Cited by 591
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Lee, W.-H., Loo, C.-Y., Bebawy, M., Luk, F., Mason, R., & Rohanizadeh, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040002 · Cited by 537
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.119 · Cited by 392
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Zhang, Y.-W., Shi, J., Li, Y.-J., & Wei, L. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0051-8 · Cited by 387
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Nanotechnology-based approaches in anticancer research
Kamal, M. A., Jabir NR, N., Tabrez, Ashraf, Shakil, & Damanhouri (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33838 · Cited by 363
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)
Helgason, T., Awad, T. S., Kristbergsson, K., McClements, D. J., & Weiss, J. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.03.012 · Cited by 340
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
Darwis, Y., Ali Khan, A., Mudassir, J., & Mohtar, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41521 · Cited by 333
Luo, Y., Teng, Z., Li, Y., & Wang, Q. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.084 · Cited by 332
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
Pirillo, A., & Catapano, A. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.032 · Cited by 305
Schnitzer, T. J., Bone, H. G., Crepaldi, G., Adámi, S., McClung, M. R., Kiel, D. P., Felsenberg, D., Recker, R. R., Tonino, R. P., Roux, C., et al. (2000) · PubMed · Cited by 299
Disorders of iron metabolism. Part II: iron deficiency and iron overload
Muñoz, M., García-Erce, J. A., & Remacha, Á. F. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.086991 · Cited by 292
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol
Pandita, D., Kumar, S., Poonia, N., & Lather, V. (2014) · Food Research International · doi:10.1016/j.foodres.2014.05.059 · Cited by 273
Beneficial action of resveratrol: How and why?
Diaz-Gerevini, G. T., Repossi, G., Dain, A., Tarres, M. C., Das, U. N., & Eynard, A. R. (2016) · Nutrition · doi:10.1016/j.nut.2015.08.017 · Cited by 260
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.017 · Cited by 252
Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols
Hu, B., Liu, X., Zhang, C., & Zeng, X. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.11.004 · Cited by 252
Uhr, M., Grauer, M. T., & Holsboer, F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00074-x · Cited by 237
Yuan, H., Chen, C.-Y., Chai, G.-H., Du, Y.-Z., & Hu, F.-Q. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300649z · Cited by 234
Self-citationKakkar, V., Muppu, S. K., Chopra, K., & Kaur, I. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.02.005 · Cited by 222
Chemopreventive Properties of Dietary Rice Bran: Current Status and Future Prospects
Henderson, A. J., Ollila, C. A., Kumar, A., Borresen, E. C., Raina, K., Agarwal, R., & Ryan, E. P. (2012) · Advances in Nutrition · doi:10.3945/an.112.002303 · Cited by 216
Kakkar, V., & Kaur, I. P. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.08.006 · Cited by 212
Ramalingam, P., & Ko, Y. T. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1469-1 · Cited by 206
Kushwaha, A. K., Vuddanda, P. R., Karunanidhi, P., Singh, S. K., & Singh, S. (2013) · BioMed Research International · doi:10.1155/2013/584549 · Cited by 201
Makwana, V., Jain, R., Patel, K., Nivsarkar, M., & Joshi, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.014 · Cited by 189
X-ray scattering characterisation of nanoparticles
Ingham, B. (2015) · Crystallography Reviews · doi:10.1080/0889311x.2015.1024114 · Cited by 187
Drug targeting using solid lipid nanoparticles
Rostami, E., Kashanian, S., Azandaryani, A. H., Faramarzi, H., Dolatabadi, J. E. N., & Omidfar, K. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.03.006 · Cited by 183
The mucosal immune system at the gastrointestinal barrier
Schenk, M., & Mueller, C. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.11.002 · Cited by 181
Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs
Ezzati Nazhad Dolatabadi, J., Valizadeh, H., & Hamishehkar, H. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.022 · Cited by 171
Kim, D.-D., Cho, H.-J., Park, J. W., & Yoon, I.-S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s56648 · Cited by 162
Ramalingam, P., & Ko, Y. T. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.11.050 · Cited by 161
Theranostic nanomedicine for cancer detection and treatment
Fan, Z., Fu, P. P., Yu, H., & Ray, P. C. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.001 · Cited by 160
Zhang, Z., Gao, F., Bu, H., Xiao, J., & Li, Y. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.016 · Cited by 159
Xue, M., Yang, M.-X., Zhang, W., Li, X.-M., Gao, D., Ou, Z., Li, Z., Li, X., Liu, S.-H., & Yang, S. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51262 · Cited by 157
Dudhipala, N. R., & Veerabrahma, K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.914986 · Cited by 157
High melting lipid based approach for drug delivery: Solid lipid nanoparticles
Kumar, S., & Randhawa, J. K. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.01.037 · Cited by 156
Bhandari, R., & Kaur, I. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.042 · Cited by 156
Ji, H., Tang, J., Li, M., Ren, J., Zheng, N., & Wu, L. (2014) · Drug Delivery · doi:10.3109/10717544.2014.918677 · Cited by 149
Microfabrication technologies for oral drug delivery
Sant, S., Tao, S. L., Fisher, O. Z., Xu, Q., Peppas, N. A., & Khademhosseini, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.013 · Cited by 149
Isoniazid: Metabolic Aspects and Toxicological Correlates
Preziosi, P. (2007) · Current Drug Metabolism · doi:10.2174/138920007782798216 · Cited by 146
Chalikwar, S. S., Belgamwar, V. S., Talele, V. R., Surana, S. J., & Patil, M. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.04.027 · Cited by 146
Chai, G., Xu, Y., Chen, S., Cheng, B., Hu, F., You, J., Du, Y., & Yuan, H. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00821 · Cited by 144
Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., & Tsai, Y.-H. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22285 · Cited by 137
Self-citationApplication of polymeric nanoparticles and micelles in insulin oral delivery
Alai, M. S., Lin, L., & Pingale, S. S. (2015) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2015.01.007 · Cited by 133
Vedagiri, A., & Sumathi, T. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.03.002 · Cited by 127
Recent approaches of lipid-based delivery system for lymphatic targeting via oral route
Chaudhary, S., Garg, T., Murthy, R. S. R., Rath, G., & Goyal, A. K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.950664 · Cited by 120
Bioactivity of Grape Chemicals for Human Health
Iriti, M., & Faoro, F. (2009) · Natural Product Communications · doi:10.1177/1934578x0900400502 · Cited by 119
Silva, A. C., Kumar, A., Wild, W., Ferreira, D., Santos, D. F. G., & Forbes, B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.058 · Cited by 118
Ansari, M. J., Anwer, M. K., Jamil, S., Al-Shdefat, R., Ali, B. E., Ahmad, M. M., & Ansari, M. N. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1039666 · Cited by 115
Kakkar, V., Mishra, A. K., Chuttani, K., & Kaur, I. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.046 · Cited by 114
Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles
Gathirwa, J. W., Omwoyo, W. N., Ogutu, B. R., Oloo, F. A., Swai, H., Kalombo, L., Melariri, P. E., & Maroa, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s62630 · Cited by 113
Ramalingam, P., Yoo, S. W., & Ko, Y. T. (2016) · Food Research International · doi:10.1016/j.foodres.2016.03.031 · Cited by 113
Fan, T., Chen, C., Guo, H., Xu, J., Zhang, J., Zhu, X. D., Yang, Y., Zhou, Z., Li, L., & Huang, Y. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.06.011 · Cited by 112
Self-citationOral delivery of salmon calcitonin
Lee, Y.-H., & Sinko, P. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00063-6 · Cited by 108
Hunter, A. C., Elsom, J., Wibroe, P. P., & Moghimi, S. M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.07.005 · Cited by 108
Gonçalves, L., Maestrelli, F., Mannelli, L. D. C., Ghelardini, C., Almeida, A. J., & Mura, P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.02.012 · Cited by 106
Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer
Bak, A., Leung, D., Barrett, S. E., Forster, S. P., Minnihan, E. C., Leithead, A., Cunningham, J., Toussaint, N., & Crocker, L. S. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9688-2 · Cited by 103
Cyclodextrin containing biodegradable particles: From preparation to drug delivery applications
Zafar, N., Fessi, H., & Elaïssari, A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.004 · Cited by 103
Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability
Yassin, A. E. B., Ibrahim, W., & Alomrani, A. H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s54413 · Cited by 103
Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy
Nakagawa, T., Yokozawa, T., TERASAWA, K., & Nakanishi, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702450 · Cited by 102
Raggi, M., Mandrioli, R., Sabbioni, C., & Pucci, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456089 · Cited by 100
Pooja, D., Kulhari, H., Kuncha, M., Rachamalla, S. S., Adams, D. J., Bansal, V., & Sistla, R. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00691 · Cited by 100
Yap, S. P., Yuen, K. H., & Lim, A. B. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2003.tb02433.x · Cited by 98
Dwivedi, P., Khatik, R., Khandelwal, K., Taneja, I., Kanumuri, R. S., Wahajuddin, M., Paliwal, S., Dwivedi, A. K., & Mishra, P. R. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.036 · Cited by 94
Hendrikx, J. J. M. A., Lagas, J. S., Rosing, H., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27912 · Cited by 93
Ozaki, K., Kishikawa, F., Tanaka, M., Sakamoto, T., Tanimura, S., & Kohno, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00669.x · Cited by 92
Doktorovová, S., Santos, D. L., Costa, I. H. D. S. E., Andreani, T., Souto, E. B., & Silva, A. M. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.011 · Cited by 88
A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles
Zariwala, M. G., Elsaid, N., Jackson, T. L., López, F. C., Farnaud, S., Somavarapu, S., & Renshaw, D. W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.070 · Cited by 83
Tran, T. H., Ramasamy, T., Truong, D. H., Shin, B. S., Choi, H., Yong, C. S., & Kim, J. O. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1300-z · Cited by 81
Solid lipid nanoparticles modified with stearic acid–octaarginine for oral administration of insulin
Lv, H., Zhang, Z., Zhang, Y., Wang, X., Xu, X.-R., Zhou, J., & Huo, W. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31711 · Cited by 80
Hosny, K. M., Banjar, Z. M., Hariri, A. H., & Hassan, A. H. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s77702 · Cited by 79
Thakkar, A. D., Chenreddy, S., Wang, J., & Prabhu, S. V. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0041-y · Cited by 74
Apetz, N., Münch, G. W., Govindaraghavan, S., & Gyengési, E. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917110635 · Cited by 74
Hwang, T., Aljuffali, I. A., Hung, C., Chen, C., & Fang, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.011 · Cited by 73
Self-citationChen, C., Fan, T., Jin, Y., Zhou, Z., Yang, Y., Zhu, X. D., Zhang, Z., Zhang, Q., & Huang, Y. (2012) · Nanomedicine · doi:10.2217/nnm.12.141 · Cited by 70
Self-citationSumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential
Girotra, P., Singh, S. K., & Kumar, P. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.035 · Cited by 68
Apomorphine in Dopaminergic Therapy
Subramony, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060012c · Cited by 67
Ahmad, J., Amin, S., Rahman, M., Rub, R. A., Singhal, M., Ahmad, M. Z., Rahman, Z., Addo, R. T., Ahmad, F. J., Mushtaq, G., et al. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150812122128 · Cited by 64
Mansourpour, M., Mahjub, R., Amini, M., Ostad, S. N., Shamsa, E. S., Tehrani, M. R., & Dorkoosh, F. A. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-014-0282-9 · Cited by 60
Baek, J.-S., So, J.-W., Shin, S., & Cho, C. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1086 · Cited by 60
Hypolipidemic Effects of Andrographolide and Neoandrographolide in Mice and Rats
Yang, T., Shi, H., Wang, Z., & Wang, C. (2012) · Phytotherapy Research · doi:10.1002/ptr.4771 · Cited by 57
Liu, Y., Wang, P., Sun, C., Zhao, J., Du, Y., Shi, F., & Feng, N. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.019 · Cited by 56
Tran, T. H., Ramasamy, T., Cho, H. J., Kim, Y. I., Poudel, B. K., Choi, H., Yong, C. S., & Kim, J. O. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.8722 · Cited by 56
Oral nanomedicine approaches for the treatment of psychiatric illnesses
Dening, T. J., Rao, S., Thomas, N., & Prestidge, C. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.047 · Cited by 55
Dissecting the Pharmacophore of Curcumin. Which Structural Element Is Critical for Which Action?
Minassi, A., Sánchez‐Duffhues, G., Collado, J. A., Muñóz, E., & Appendino, G. (2013) · Journal of Natural Products · doi:10.1021/np400148e · Cited by 50
Hosny, K. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154926 · Cited by 48
Nanomedical Strategies for Targeting Skin Microbiomes
Aljuffali, I. A., Huang, C., & Fang, J. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150812124923 · Cited by 43
Self-citationIn vitrocytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate
Hashem, F. M., Nasr, M., & Khairy, A. (2013) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2013.836218 · Cited by 36
Girotra, P., & Singh, S. K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0532-0 · Cited by 36
Negi, J. S., Chattopadhyay, P., Sharma, A. K., & Ram, V. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0154-y · Cited by 33
Regulation of NF-Κb Activity in Astrocytes: Effects of Flavonoids at Dietary-Relevant Concentrations
Spilsbury, A., Vauzour, D., Spencer, J. P. E., & Rattray, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.081 · Cited by 32
Zhou, Y., Zhang, G., Rao, Z., Yang, Y., Zhou, Q., Qin, H., Wei, Y., & Wu, X. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0539-6 · Cited by 27
Novel Modified Nanosystem Based Lymphatic Targeting
Saraf, S., Ghosh, A., Kaur, C. D., & Saraf, S. (2011) · Research Journal of Nanoscience and Nanotechnology · doi:10.3923/rjnn.2011.60.74 · Cited by 27
Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
Gündoğdu, E., & Yurdasiper, A. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.8984 · Cited by 26
Skeletal and nonskeletal effects of raloxifene
Gluck, O. S., & Maricic, M. J. (2003) · Current Osteoporosis Reports · doi:10.1007/s11914-996-0007-4 · Cited by 11
Cited by
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Bayón-Cordero, L., Alkorta, I., & Arana, L. (2019) · Nanomaterials · doi:10.3390/nano9030474 · Cited by 344
Recent updates on drug resistance in Mycobacterium tuberculosis
Singh, R., Dwivedi, S. P., Gaharwar, U. S., Meena, R., Rajamani, P., & Prasad, T. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14478 · Cited by 337
Solid lipid nanoparticles: a review on recent perspectives and patents
Paliwal, R., Paliwal, S. R., Kenwat, R., Kurmi, B. D., & Sahu, M. K. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1720649 · Cited by 337
Metadata
- Authors
- Lin, C.-H., Chen, C.-H., Lin, Z.-C., & Fang, J.-Y.
- Venue
- Journal of Food and Drug Analysis
- Published
- 2017-04
- Volume
- 25
- Issue
- 2
- Pages
- 219-234
- ISSN
- 1021-9498 (ISSN-L)
- OpenAlex
- W2595124104
- Cited by
- 298
- References
- 108
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.